CHEK1 and neoplasm: Cell cycle checkpoint inhibition is still in its infancy but while ATM, CHK1, and WEE1 inhibitors resulted in successful sensitization of various tumor types, including primary brain tumors, ATM and CHK2 inhibitors are less studied in brain tumors.